BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25542838)

  • 1. Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida.
    Xiao H; Tan F; Goovaerts P; Adunlin G; Ali AA; Gwede CK; Huang Y
    Am J Mens Health; 2016 Jul; 10(4):285-95. PubMed ID: 25542838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.
    Xiao H; Tan F; Goovaerts P; Ali A; Adunlin G; Gwede CK; Huang Y
    Am J Mens Health; 2014 Jul; 8(4):316-26. PubMed ID: 24297455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insurance status as a modifier of the association between race and stage of prostate cancer diagnosis in Florida during 1995 and 2013.
    Ramirez E; Morano J; Beguiristain T; Castro G; de la Vega PR; Nieder AM; Barengo NC
    Cancer Epidemiol; 2019 Apr; 59():104-108. PubMed ID: 30731402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographical, temporal and racial disparities in late-stage prostate cancer incidence across Florida: a multiscale joinpoint regression analysis.
    Goovaerts P; Xiao H
    Int J Health Geogr; 2011 Dec; 10():63. PubMed ID: 22142274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prostate cancer incidence using geographic information system and multilevel modeling.
    Xiao H; Gwede CK; Kiros G; Milla K
    J Natl Med Assoc; 2007 Mar; 99(3):218-25. PubMed ID: 17393945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
    Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
    JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and geographic disparities in late-stage prostate cancer diagnosis in Florida.
    Xiao H; Tan F; Goovaerts P
    J Health Care Poor Underserved; 2011; 22(4 Suppl):187-99. PubMed ID: 22102314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
    Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL
    Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Social Determinants on Late Stage Breast Cancer for Women in Mississippi.
    Fortune ML
    J Racial Ethn Health Disparities; 2017 Feb; 4(1):104-111. PubMed ID: 26902946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer sociodemographic and diagnostic disparities in Florida: a population-based study (1981-2013) by stage at presentation.
    Gauri A; Messiah SE; Bouzoubaa LA; Moore KJ; Koru-Sengul T
    Ethn Health; 2020 Oct; 25(7):995-1003. PubMed ID: 29732918
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of health insurance and race on early detection of cancer.
    Roetzheim RG; Pal N; Tennant C; Voti L; Ayanian JZ; Schwabe A; Krischer JP
    J Natl Cancer Inst; 1999 Aug; 91(16):1409-15. PubMed ID: 10451447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients.
    Oakley-Girvan I; Kolonel LN; Gallagher RP; Wu AH; Felberg A; Whittemore AS
    Am J Public Health; 2003 Oct; 93(10):1753-9. PubMed ID: 14534233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in survival after diagnosis of prostate cancer in Kentucky, 2001-2010.
    Antwi S; Tucker TC; Coker AL; Fleming ST
    Am J Mens Health; 2013 Jul; 7(4):306-16. PubMed ID: 23339130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data.
    Xiao H; Tan F; Goovaerts P; Ali A; Adunlin G; Huang Y; Gwede C
    J Registry Manag; 2013; 40(4):159-64. PubMed ID: 24625768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities in late-stage prostate cancer: a SEER analysis 2005-2015.
    Rodriguez S; Sparks AD; Zhou H; Amdu RL; Lin J
    Can J Urol; 2019 Oct; 26(5):9946-9951. PubMed ID: 31629445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities and the risk of late-stage prostate cancer.
    Fleming ST; McDavid K; Pearce K; Pavlov D
    ScientificWorldJournal; 2006 Jul; 6():2460-70. PubMed ID: 17619718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of Social Factors to Disparities in Prostate Cancer Risk Profiles among Black Men and Non-Hispanic White Men with Prostate Cancer in California.
    Press DJ; Shariff-Marco S; Lichtensztajn DY; Lauderdale D; Murphy AB; Inamdar PP; DeRouen MC; Hamilton AS; Yang J; Lin K; Hedeker D; Haiman CA; Cheng I; Gomez SL
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):404-412. PubMed ID: 34853020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.